EE201 Cost-Effectiveness of Romiplostim for the Treatment of Patients with Early Immune Thrombocytopenia in the Czech Republic

Autor:	C van Beurden-Tan, Z Kucera, B Pasztor, S Vesela, L Cervinek, E Konirova, T Kozak, IM Majer
Rok vydání:	2022
Předmět:	Health Policy Public Health Environmental and Occupational Health
Zdroj:	Value in Health. 25:S372-S373
ISSN:	1098-3015
DOI:	10.1016/j.jval.2022.04.450
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::0955fe97a6aedad29dc9b8427d1fec7f https://doi.org/10.1016/j.jval.2022.04.450 Zobrazit plný text záznamu Full Text from ScienceDirect